{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T04:39:54Z","timestamp":1784349594163,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Delta University for Science and Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    By carefully hybridizing with scaffolds generated from chromene, pyranochromene, and cyanoacetamide, a novel class of phenothiazine-based heterocycles was created. IR, NMR, and MS investigations were used to establish the structural integrity of each molecule. Several derivatives showed considerable inhibitory activity, especially compounds\n                    <jats:bold>4<\/jats:bold>\n                    ,\n                    <jats:bold>7<\/jats:bold>\n                    , and\n                    <jats:bold>10<\/jats:bold>\n                    , which had MIC values ranging from 3.9 to 15.6\u00a0\u00b5g\/mL against both Gram-positive and Gram-negative bacteria, according to the antimicrobial assessment. The majority of compounds met Lipinski\u2019s criteria, indicating favorable oral bioavailability, according to the drug-likeness assessment. Significant binding affinity was shown by molecular docking against Staphylococcus aureus \u03b2-lactamase (PDB: 3G7B). Compound\n                    <jats:bold>7<\/jats:bold>\n                    had the best docking score (\u20135.99\u00a0kcal\/mol), followed by compound\n                    <jats:bold>4<\/jats:bold>\n                    (\u20135.86\u00a0kcal\/mol), which was supported by important hydrophobic and hydrogen-bonding interactions with Asp73, Arg76, and Lys103. These findings demonstrate the possibility of phenothiazine\u2013chromene hybrids as viable options for creating novel antimicrobial medicines that effectively combat infections that are resistant to multiple drugs.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-43195-3","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:36:11Z","timestamp":1774884971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Synthesis, antimicrobial evaluation, molecular docking, and drug-likeness assessment of novel phenothiazine chromene hybrid compounds"],"prefix":"10.1038","volume":"16","author":[{"given":"Nesma M.","family":"Bayoumy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Fadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem E.","family":"Gaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanees N.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"43195_CR1","first-page":"3","volume":"398","author":"E Medina","year":"2016","unstructured":"Medina, E. & Pieper, D. H. Tackling threats and future problems of multidrug-resistant bacteria. Curr. Top. Microbiol. Immunol. 398, 3 (2016).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"43195_CR2","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1089\/mdr.2018.0319","volume":"25","author":"R Vivas","year":"2019","unstructured":"Vivas, R., Barbosa, A. A. T., Dolabela, S. S. & Jain, S. Multidrug-resistant bacteria and alternative methods to control them: an overview. Microb. Drug Resist. 25, 890 (2019).","journal-title":"Microb. Drug Resist."},{"key":"43195_CR3","doi-asserted-by":"publisher","first-page":"115733","DOI":"10.1016\/j.ejmech.2023.115733","volume":"260","author":"Q Yu","year":"2023","unstructured":"Yu, Q. et al. Design of phenothiazine-based cationic amphiphilic derivatives incorporating arginine residues: potential membrane-active broad-spectrum antimicrobials combating pathogenic bacteria in vitro and in vivo. Eur. J. Med. Chem. 260, 115733 (2023).","journal-title":"Eur. J. Med. Chem."},{"key":"43195_CR4","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1111\/jam.15109","volume":"131","author":"L Aguilar-Vega","year":"2021","unstructured":"Aguilar-Vega, L. et al. Antibacterial properties of phenothiazine derivatives against multidrug-resistant Acinetobacter baumannii strains. J. Appl. Microbiol. 131, 2235 (2021).","journal-title":"J. Appl. Microbiol."},{"key":"43195_CR5","first-page":"1","volume":"1","author":"M Asif","year":"2015","unstructured":"Asif, M. Chemical and pharmacological potential of various substituted thiazine derivatives. J. Pharm. Appl. Chem. 1, 1 (2015).","journal-title":"J. Pharm. Appl. Chem."},{"key":"43195_CR6","first-page":"54","volume":"10","author":"H Kenia","year":"2020","unstructured":"Kenia, H. et al. Synthesis and evaluation of phenothiazine derivatives. IOSR J. Pharm. 10, 54 (2020).","journal-title":"IOSR J. Pharm."},{"key":"43195_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2174\/2211352516666180730121013","volume":"17","author":"SK Singh","year":"2019","unstructured":"Singh, S. K., Nath, G., Kumar, A. & Sellamuthu, S. K. Design, synthesis and biological profiling of novel phenothiazine derivatives as potent antitubercular agents. Anti-Infect Agents. 17, 50 (2019).","journal-title":"Anti-Infect Agents"},{"key":"43195_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1365-3156.2005.01417.x","volume":"10","author":"M Wainwright","year":"2005","unstructured":"Wainwright, M. & Amaral, L. The phenothiazinium chromophore and the evolution of antimalarial drugs. Trop. Med. Int. Health. 10, 501 (2005).","journal-title":"Trop. Med. Int. Health"},{"key":"43195_CR9","doi-asserted-by":"publisher","first-page":"5701","DOI":"10.21873\/anticanres.11153","volume":"36","author":"G Spengler","year":"2016","unstructured":"Spengler, G., Csonka, \u00c1., Molnar, J. & Amaral, L. The anticancer activity of the old neuroleptic phenothiazine-type drug thioridazine. Anticancer Res. 36, 5701 (2016).","journal-title":"Anticancer Res."},{"key":"43195_CR10","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1080\/10406638.2021.2021254","volume":"43","author":"K Venkatesan","year":"2023","unstructured":"Venkatesan, K., Satyanarayana, V. S. V. & Sivakumar, A. Synthesis and biological evaluation of novel phenothiazine derivatives as potential antitumor agents. Polycycl. Aromat. Compd. 43, 850 (2023).","journal-title":"Polycycl. Aromat. Compd."},{"key":"43195_CR11","doi-asserted-by":"publisher","first-page":"133012","DOI":"10.1016\/j.molstruc.2022.133012","volume":"1263","author":"MK Katiyar","year":"2022","unstructured":"Katiyar, M. K. et al. Synthetic strategies and pharmacological activities of chromene and its derivatives: an overview. J. Mol. Struct. 1263, 133012 (2022).","journal-title":"J. Mol. Struct."},{"key":"43195_CR12","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.2174\/1389557522666220331161636","volume":"22","author":"A Chaudhary","year":"2022","unstructured":"Chaudhary, A. et al. Chromenes: a novel class of heterocyclic compounds recent advancements and future directions. Mini.  Rev. Med. Chem. 22, 2736 (2022).","journal-title":"Mini Rev. Med. Chem."},{"key":"43195_CR13","doi-asserted-by":"publisher","first-page":"127037","DOI":"10.1016\/j.molstruc.2019.127037","volume":"1199","author":"KG Krishnan","year":"2020","unstructured":"Krishnan, K. G. et al. Novel cyanoacetamide integrated phenothiazines: synthesis, characterization, computational studies and in vitro antioxidant and anticancer evaluations. J. Mol. Struct. 1199, 127037 (2020).","journal-title":"J. Mol. Struct."},{"key":"43195_CR14","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1039\/C9GC03692J","volume":"22","author":"L Kong","year":"2020","unstructured":"Kong, L. et al. Multi-component solvent-free cascade reaction of 2-cyanoacetamides: regioselective synthesis of pyridin-2-ones bearing quaternary centers. Green. Chem. 22, 256 (2020).","journal-title":"Green. Chem."},{"key":"43195_CR15","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/jhet.3452","volume":"56","author":"AA Fadda","year":"2019","unstructured":"Fadda, A. A., Abdel-Latif, E., Fekri, A. & Mostafa, A. R. Synthesis and docking studies of some 1,2,3-benzotriazine-4-one derivatives as potential anticancer agents. J. Heterocycl. Chem. 56, 804 (2019).","journal-title":"J. Heterocycl. Chem."},{"key":"43195_CR16","doi-asserted-by":"publisher","first-page":"39773","DOI":"10.1039\/C7RA06087D","volume":"7","author":"AA Fadda","year":"2017","unstructured":"Fadda, A. A., Abd El Salam, M., Tawfik, E. H., Anwar, E. M. & Etman, H. A. Synthesis and insecticidal assessment of some innovative heterocycles incorporating a thiadiazole moiety against the cotton leafworm, Spodoptera littoralis. RSC Adv. 7, 39773 (2017).","journal-title":"RSC Adv."},{"key":"43195_CR17","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1080\/10406638.2019.1636832","volume":"41","author":"NM Bayoumy","year":"2021","unstructured":"Bayoumy, N. M., Fekri, A., Tawfik, E. H. & Fadda, A. A. Synthesis, characterization and antimicrobial evaluation of some new heterocycles incorporating phenothiazine moiety. Polycycl. Aromat. Compd. 41, 982 (2021).","journal-title":"Polycycl. Aromat. Compd."},{"key":"43195_CR18","doi-asserted-by":"publisher","first-page":"80844","DOI":"10.1039\/C5RA14723A","volume":"5","author":"AA Fadda","year":"2015","unstructured":"Fadda, A. A., Fekri, A. & Bayoumy, N. M. Synthesis, antimicrobial evaluation and molecular modeling of some novel phenothiazine derivatives. RSC Adv. 5, 80844 (2015).","journal-title":"RSC Adv."},{"key":"43195_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ijpharm.2018.07.046","volume":"549","author":"CM Chagas","year":"2018","unstructured":"Chagas, C. M., Moss, S. & Alisaraie, L. Drug metabolites and their effects on the development of adverse reactions: revisiting Lipinski\u2019s rule of five. Int. J. Pharm. 549, 133 (2018).","journal-title":"Int. J. Pharm."},{"key":"43195_CR20","first-page":"292","volume":"25","author":"A Do\u011fan","year":"2021","unstructured":"Do\u011fan, A., \u00d6zdemir, S., Yal\u00e7\u0131n, M. S., Sar\u0131, H. & Nural, Y. Naphthoquinone\u2013thiazole hybrids bearing adamantane: synthesis, antimicrobial, DNA cleavage, antioxidant activity, acid dissociation constant, and drug-likeness. J. Res. Pharm. 25, 292 (2021).","journal-title":"J. Res. Pharm."},{"key":"43195_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00706-020-02550-4","volume":"151","author":"S Ghannay","year":"2020","unstructured":"Ghannay, S., Kadri, A. & Aouadi, K. Synthesis, in vitro antimicrobial assessment, and computational investigation of pharmacokinetic and bioactivity properties of novel trifluoromethylated compounds using in silico ADME and toxicity prediction tools. Monatsh Chem. 151, 267 (2020).","journal-title":"Monatsh Chem."},{"key":"43195_CR22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/slct.202003919","volume":"6","author":"N Nehra","year":"2021","unstructured":"Nehra, N. et al. CuAAC mediated synthesis of 2-HBT linked bioactive 1,2,3-triazole hybrids: investigations through fluorescence, DNA binding, molecular docking, ADME predictions and DFT study. ChemistrySelect 6, 685 (2021).","journal-title":"ChemistrySelect"},{"key":"43195_CR23","doi-asserted-by":"publisher","first-page":"e2925","DOI":"10.1002\/jmr.2925","volume":"34","author":"R Rajalakshmi","year":"2021","unstructured":"Rajalakshmi, R. et al. In silico studies: physicochemical properties, drug score, toxicity predictions and molecular docking of organosulphur compounds against diabetes mellitus. J. Mol. Recognit. 34, e2925 (2021).","journal-title":"J. Mol. Recognit."},{"key":"43195_CR24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ejmech.2012.11.017","volume":"60","author":"AA Fadda","year":"2013","unstructured":"Fadda, A. A., Afsah, E. S. M. & Awad, R. S. Synthesis and antimicrobial activity of some new benzo and naphthonitrile derivatives. Eur. J. Med. Chem. 60, 421 (2013).","journal-title":"Eur. J. Med. Chem."},{"key":"43195_CR25","doi-asserted-by":"publisher","first-page":"e202402223","DOI":"10.1002\/slct.202402223","volume":"9","author":"SP Parida","year":"2024","unstructured":"Parida, S. P. et al. [4\u2009+\u20092] cycloaddition mediated stereoselective synthesis of tetrahydro-1H-isobenzofuro chromene dione derivatives: antibacterial evaluation and molecular docking investigation. ChemistrySelect 9, e202402223 (2024).","journal-title":"ChemistrySelect"},{"key":"43195_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/jac\/48.suppl_1.5","volume":"48","author":"JM Andrews","year":"2001","unstructured":"Andrews, J. M. Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 48, 5 (2001).","journal-title":"J. Antimicrob. Chemother."},{"key":"43195_CR27","unstructured":"Field, A. Discovering Statistics Using IBM SPSS Statistics. Sage (2013)."},{"key":"43195_CR28","unstructured":"Zar, J. H. Biostatistical Analysis. Pearson (2010)."},{"key":"43195_CR29","unstructured":"Kaufman, L. & Rousseeuw, P. J. Finding Groups in Data (Wiley, 2009)."},{"key":"43195_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jpha.2015.11.005","volume":"6","author":"M Balouiri","year":"2016","unstructured":"Balouiri, M., Sadiki, M. & Ibnsouda, S. K. Methods for in vitro evaluating antimicrobial activity. J. Pharm. Anal. 6, 71 (2016).","journal-title":"J. Pharm. Anal."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43195-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43195-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43195-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:44:49Z","timestamp":1774950289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43195-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43195"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43195-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10592"}}